Skip to content
Middletown Life
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Lexaria Bioscience Corp.
Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 4, 2026
Lexaria Receives USD$2.6 Million Tax Rebate Payment
September 1, 2026
DehydraTECH(TM)-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria’s 2026 Animal Study #2
August 24, 2026
Lexaria Enters a Material Transfer Agreement With PegBio
August 13, 2026
Lexaria Announces Effective Date for Reverse Stock Split
July 30, 2026
Lexaria Updates Business Development
July 6, 2026
Lexaria’s Human Study GLP-1-H26-7 Has Begun Dosing on Schedule
June 25, 2026
Lexaria’s Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule
June 23, 2026
GLP-1 ‘Arms Race’ Intensifies as the Addressable Markets Continue to Expand
June 17, 2026
Lexaria’s Animal Study Examining Next-Generation GLP-1 drugs is Underway
June 9, 2026
1
2
3
Next Page
→